Related Experiment Videos
Complement in local biliary tract defense: dissociation between bile complement and acute phase reactants in
The Journal of Surgical Research
|April 1, 1987
Summary
Bile complement levels are lower in infected bile, suggesting a targeted defense against biliary tract infections, not a systemic inflammatory response. This highlights bile complement
Area of Science:
- Gastroenterology and Immunology
- Biliary Tract Pathophysiology
Background:
- Biliary complement concentrations are lower in infected bile compared to sterile bile.
- Plasma complement increases during systemic inflammation (acute phase response).
- The role of biliary complement in cholecystitis requires clarification.
Purpose of the Study:
- To investigate if low biliary complement in infected bile reflects a specific biliary tract infection response or a general systemic reaction.
- To analyze biliary complement proteins (C3, C4) and activity (C4H50) alongside acute phase reactants in cholecystitis.
Main Methods:
- Analysis of bile complement (C3, C4, C4H50) and acute phase reactants (fibronectin, C-reactive protein, alpha 1-antitrypsin) in acute and chronic cholecystitis.
- Correlation of biliary analytes with bile cultures and gallbladder histology.
- Statistical analysis using the Wilcoxon rank sum test.
Main Results:
- Biliary C3, C4, and C4H50 were significantly lower in infected bile versus sterile bile.
- No significant difference in acute phase reactants between infected and sterile bile.
- Biliary acute phase reactants were higher in acute cholecystitis than chronic, but biliary complement levels did not differ between these groups.
- No clear correlation between plasma complement levels and acute phase reactants.
Conclusions:
- Biliary complement levels are specifically reduced in infected bile, indicating a localized response.
- The dissociation between biliary complement and systemic acute phase reactants suggests bile complement is not merely a marker of systemic inflammation.
- Biliary complement is proposed as a specific host defense mechanism against bacterial infections within the biliary tract.